TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

TT

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

TT

ST13

US500000098081069

Classe

5, 9, 42, 44

Pedido

98081069

Registro

7718400

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

41

Atualização mais recente

03/05/2025

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

5, 9, 42, 44

Data de depósito

12/07/2023

Data de registro

11/03/2025

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

11/03/2025

Última transação

03/05/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Foreign priority

Código do desenho

3

Tipo de titular

99

Localização do titular

Cambridge, GB

Examinador

ANDERSON, DANIELLE

Localização atual

FILE REPOSITORY (FRANCONIA)

Descrição da marca

The mark consists of an abstract design in the color light blue, within which is a white upside down letter T on top of a white right side up letter T.

Titulares e representantes

Titulares

T-Therapeutics Limited

Representantes

Stacy J. Grossman SGIP

Classificação técnica

Classes Nice

Classe 5Classe 9Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Pharmaceutical preparations for protection from and prevention of viral and bacterial infections, cancer, inflammation, infectious diseases and non-infectious diseases, namely, musculoskeletal, cardiovascular, cardiopulmonary, oncological, neurological, dermatological, genitourinary, sexual dysfunction, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, psychiatric and immune system diseases and disorders; chemical and biological pharmaceutical preparations for medical purposes, namely, for protection from and prevention of viral and bacterial infections, cancer, inflammation, infectious diseases and non-infectious diseases, namely, musculoskeletal, cardiovascular, cardiopulmonary, oncological, neurological, dermatological, genitourinary, sexual dysfunction, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, psychiatric and immune system diseases and disorders; chemical preparations for use in DNA analysis for medical purposes; DNA synthesis inhibitors for medical purposes, namely, pharmaceutical preparations for protection from and prevention of viral and bacterial infections, cancer, inflammation, infectious diseases and non-infectious diseases, namely, musculoskeletal, cardiovascular, cardiopulmonary, oncological, neurological, dermatological, genitourinary, sexual dysfunction, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, psychiatric and immune system diseases and disorders; biological preparations for the treatment of cancer; biological preparations for the treatment of viral and bacterial infections; biological preparations for the treatment of autoimmune diseases; biological preparations for medical use for the treatment of viral and bacterial infections, cancer, inflammation, infectious diseases and non-infectious diseases, namely, musculoskeletal, cardiovascular, cardiopulmonary, oncological, neurological, dermatological, genitourinary, sexual dysfunction, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, psychiatric and immune system diseases and disorders; immunotherapeutic drugs namely, pharmaceutical preparations for protection from and prevention of viral and bacterial infections, cancer, inflammation, infectious diseases and non-infectious diseases, namely, musculoskeletal, cardiovascular, cardiopulmonary, oncological, neurological, dermatological, genitourinary, sexual dysfunction, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, psychiatric and immune system diseases and disorders; reagents for medical use; diagnostic preparations for medical use; diagnostic reagents for medical use; preparations for detecting genetic predispositions for medical purposes

Classe 9

Downloadable computer software for use in collecting, analyzing and organizing data in the field of pharmaceuticals, biopharmaceutical drug development and genome engineering; downloadable computer software for use in collecting, analyzing and organizing data in the field of scientific and pharmaceutical research and development; downloadable software for scientific modelling of pharmaceuticals in the field of scientific and pharmaceutical research and development; downloadable software for pharmaceutical modelling; downloadable software for research and development in the nature of collecting, analyzing and organizing data in the field of antibodies; devices for analyzing genome information, namely, laboratory devices for detecting genetic sequences; downloadable software for performing gene sequencing research and visualization, namely, scientific analysis of genetic sequences; downloadable software for the managing, analysis, and visualization of biological data

Classe 42

Scientific and technological services, namely, scientific research and development in the field of pharmaceuticals for genome engineering and biopharmaceutical drug development for protection from infections, cancer, disease or inflammation; technical research in the field of pharmaceutical studies; design and development of computer hardware and software; platform as a service (PAAS) featuring computer software platforms for use in database management in the field of pharmaceuticals, biopharmaceutical drug development and genome engineering; platform as a service (PAAS) featuring DNA analysis software platforms; software as a service (SAAS) services featuring software for use in database management in the field of pharmaceuticals, biopharmaceutical drug development and genome engineering; software as a service (SAAS) services featuring DNA analysis software; provision of online non-downloadable software for the management, visualization and analysis of biological data for the purposes of biomolecular research and the design and engineering of biomolecular products; DNA analysis services in the field of DNA sequencing for scientific research; provision of a web hosting platform for the analysis of DNA sequencing data for scientific research purposes and diagnostic and treatment purposes

Classe 44

Medical services; diagnostic and prognostic medical services; veterinary services; medical analysis services relating to the treatment of persons; pharmaceutical advice; medical and health care services relating to DNA, genetics, and genetic pathogen testing for diagnostic or treatment purposes; medical screening and assaying in the nature of medical laboratory analysis services relating to the treatment of persons; DNA screening for medical purposes; DNA analysis services in the field of DNA sequencing for diagnostic and treatment purposes provided by medical laboratories

Publicações

Histórico de despachos e eventos da marca no USPTO.

41 publicações encontradas

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

28/04/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

28/04/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

28/04/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

28/04/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

28/04/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

11/03/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

11/03/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

21/01/2025

PUBO

PUBLISHED FOR OPPOSITION

21/01/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

15/01/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

27/12/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

27/12/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

27/12/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

27/12/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

27/12/2024

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

16/12/2024

GNFR

FINAL REFUSAL E-MAILED

16/12/2024

CNFR

FINAL REFUSAL WRITTEN

16/12/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/11/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/11/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/11/2024

XELG

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

09/10/2024

XELR

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

09/10/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

11/07/2024

GNRT

NON-FINAL ACTION E-MAILED

11/07/2024

CNRT

NON-FINAL ACTION WRITTEN

11/07/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/06/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/06/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/06/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

31/05/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

31/05/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

31/05/2024

GRML

CORRESPONDENCE E-MAILED

27/03/2024

CNRT

NON-FINAL ACTION WRITTEN

27/03/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

27/03/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

27/03/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

27/03/2024

DOCK

ASSIGNED TO EXAMINER

20/03/2024

MDSM

NOTICE OF DESIGN SEARCH CODE E-MAILED

11/08/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/08/2023

NWAP

NEW APPLICATION ENTERED

15/07/2023

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace TT ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.